Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Yates

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Computer Methods and Programs in Biomedicine|December 18, 2010
A new general glucose homeostatic model using a proportional-integral-derivative controllerE M Watson, M J Chappell, F Ducrozet, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 11, 2015
Tumour stromal morphology impacts nanomedicine cytotoxicity in patient-derived xenograftsJuan A Delgado San Martin, Jennifer I Hare, James W T Yates, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 24, 2026
A hybrid PKPD agent-based model of the tumour immune interaction: effects of anti-cancer combination therapyVan Thuy Truong, Grant Lythe, Paolo Vicini, et al.
Molecular Cancer Therapeutics|July 22, 2016
Irreversible Inhibition of EGFR: Modeling the Combined Pharmacokinetic-Pharmacodynamic Relationship of Osimertinib and Its Active Metabolite AZ5104James W T Yates, Susan Ashton, Darren Cross, et al.
Plos Computational Biology|October 31, 2015
Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical ApproachJuan A Delgado-SanMartin, Jennifer I Hare, Alessandro P S de Moura, et al.
Clinical Pharmacology and Therapeutics|March 24, 2026
TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental DataAdam Nasim, David Fairman, Emma Nixon, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 17, 2014
Experimental and mathematical analysis of in vitro Pitavastatin hepatic uptake across speciesThomas R B Grandjean, Mike J Chappell, Alex M Lench, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 2, 2013
Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and ratsSuzanne Geenen, James W T Yates, J Gerry Kenna, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 16, 2021
Step-by-step comparison of ordinary differential equation and agent-based approaches to pharmacokinetic-pharmacodynamic modelsVan Thuy Truong, Paul G Baverel, Grant D Lythe, et al.
Journal of Pharmacological and Toxicological Methods|April 10, 2013
Translational pharmacokinetic-pharmacodynamic modeling of QTc effects in dog and humanJoanna Parkinson, Sandra A G Visser, Philip Jarvis, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Computer Methods and Programs in Biomedicine|December 18, 2010
A new general glucose homeostatic model using a proportional-integral-derivative controllerE M Watson, M J Chappell, F Ducrozet, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 11, 2015
Tumour stromal morphology impacts nanomedicine cytotoxicity in patient-derived xenograftsJuan A Delgado San Martin, Jennifer I Hare, James W T Yates, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 24, 2026
A hybrid PKPD agent-based model of the tumour immune interaction: effects of anti-cancer combination therapyVan Thuy Truong, Grant Lythe, Paolo Vicini, et al.
Molecular Cancer Therapeutics|July 22, 2016
Irreversible Inhibition of EGFR: Modeling the Combined Pharmacokinetic-Pharmacodynamic Relationship of Osimertinib and Its Active Metabolite AZ5104James W T Yates, Susan Ashton, Darren Cross, et al.
Plos Computational Biology|October 31, 2015
Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical ApproachJuan A Delgado-SanMartin, Jennifer I Hare, Alessandro P S de Moura, et al.
Clinical Pharmacology and Therapeutics|March 24, 2026
TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental DataAdam Nasim, David Fairman, Emma Nixon, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 17, 2014
Experimental and mathematical analysis of in vitro Pitavastatin hepatic uptake across speciesThomas R B Grandjean, Mike J Chappell, Alex M Lench, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 2, 2013
Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and ratsSuzanne Geenen, James W T Yates, J Gerry Kenna, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 16, 2021
Step-by-step comparison of ordinary differential equation and agent-based approaches to pharmacokinetic-pharmacodynamic modelsVan Thuy Truong, Paul G Baverel, Grant D Lythe, et al.
Journal of Pharmacological and Toxicological Methods|April 10, 2013
Translational pharmacokinetic-pharmacodynamic modeling of QTc effects in dog and humanJoanna Parkinson, Sandra A G Visser, Philip Jarvis, et al.
Pageof 8